278 related articles for article (PubMed ID: 16565390)
1. Blockade of the interaction of leukotriene b4 with its receptor prevents development of autoimmune uveitis.
Liao T; Ke Y; Shao WH; Haribabu B; Kaplan HJ; Sun D; Shao H
Invest Ophthalmol Vis Sci; 2006 Apr; 47(4):1543-9. PubMed ID: 16565390
[TBL] [Abstract][Full Text] [Related]
2. Severe chronic experimental autoimmune uveitis (EAU) of the C57BL/6 mouse induced by adoptive transfer of IRBP1-20-specific T cells.
Shao H; Liao T; Ke Y; Shi H; Kaplan HJ; Sun D
Exp Eye Res; 2006 Feb; 82(2):323-31. PubMed ID: 16125173
[TBL] [Abstract][Full Text] [Related]
3. Suppression of established experimental autoimmune uveitis by anti-LFA-1alpha Ab.
Ke Y; Sun D; Zhang P; Jiang G; Kaplan HJ; Shao H
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2667-75. PubMed ID: 17525198
[TBL] [Abstract][Full Text] [Related]
4. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
5. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.
Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models.
Sasaki F; Koga T; Ohba M; Saeki K; Okuno T; Ishikawa K; Nakama T; Nakao S; Yoshida S; Ishibashi T; Ahmadieh H; Kanavi MR; Hafezi-Moghadam A; Penninger JM; Sonoda KH; Yokomizo T
JCI Insight; 2018 Sep; 3(18):. PubMed ID: 30232269
[TBL] [Abstract][Full Text] [Related]
7. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
8. Blockade of interleukin-6 signaling suppresses not only th17 but also interphotoreceptor retinoid binding protein-specific Th1 by promoting regulatory T cells in experimental autoimmune uveoretinitis.
Haruta H; Ohguro N; Fujimoto M; Hohki S; Terabe F; Serada S; Nomura S; Nishida K; Kishimoto T; Naka T
Invest Ophthalmol Vis Sci; 2011 May; 52(6):3264-71. PubMed ID: 21330657
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene B
Eskandarpour M; Chen YH; Nunn MA; Coupland SE; Weston-Davies W; Calder VL
Am J Pathol; 2021 Feb; 191(2):320-334. PubMed ID: 33159884
[TBL] [Abstract][Full Text] [Related]
10. Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells.
Shao H; Fu Y; Liao T; Peng Y; Chen L; Kaplan HJ; Sun D
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):596-603. PubMed ID: 15671287
[TBL] [Abstract][Full Text] [Related]
11. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
[TBL] [Abstract][Full Text] [Related]
12. Use of ACAID to suppress interphotoreceptor retinoid binding protein-induced experimental autoimmune uveitis.
Hara Y; Caspi RR; Wiggert B; Chan CC; Streilein JW
Curr Eye Res; 1992; 11 Suppl():97-100. PubMed ID: 1424755
[TBL] [Abstract][Full Text] [Related]
13. CCR5-deficient mice develop experimental autoimmune uveoretinitis in the context of a deviant effector response.
Takeuchi A; Usui Y; Takeuchi M; Hattori T; Kezuka T; Suzuki J; Okunuki Y; Iwasaki T; Haino M; Matsushima K; Usui M
Invest Ophthalmol Vis Sci; 2005 Oct; 46(10):3753-60. PubMed ID: 16186359
[TBL] [Abstract][Full Text] [Related]
14. Prevention of experimental autoimmune uveoretinitis by vasoactive intestinal peptide.
Keino H; Kezuka T; Takeuchi M; Yamakawa N; Hattori T; Usui M
Arch Ophthalmol; 2004 Aug; 122(8):1179-84. PubMed ID: 15302659
[TBL] [Abstract][Full Text] [Related]
15. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.
Cortes LM; Mattapallil MJ; Silver PB; Donoso LA; Liou GI; Zhu W; Chan CC; Caspi RR
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1946-56. PubMed ID: 18436827
[TBL] [Abstract][Full Text] [Related]
16. Interphotoreceptor retinoid-binding protein (IRBP)-deficient C57BL/6 mice have enhanced immunological and immunopathogenic responses to IRBP and an altered recognition of IRBP epitopes.
Avichezer D; Liou GI; Chan CC; Lewis GM; Wiggert B; Donoso LA; Nickerson JM; Crawford MA; Caspi RR
J Autoimmun; 2003 Nov; 21(3):185-94. PubMed ID: 14599843
[TBL] [Abstract][Full Text] [Related]
17. The leukotriene B4 receptor (BLT1) is required for effector CD8+ T cell-mediated, mast cell-dependent airway hyperresponsiveness.
Taube C; Miyahara N; Ott V; Swanson B; Takeda K; Loader J; Shultz LD; Tager AM; Luster AD; Dakhama A; Gelfand EW
J Immunol; 2006 Mar; 176(5):3157-64. PubMed ID: 16493075
[TBL] [Abstract][Full Text] [Related]
18. Regulation of interphotoreceptor retinoid-binding protein (IRBP)-specific Th1 and Th17 cells in anterior chamber-associated immune deviation (ACAID).
Cui Y; Shao H; Sun D; Kaplan HJ
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5811-7. PubMed ID: 19458338
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B₄-leukotriene B₄ receptor axis promotes oxazolone-induced contact dermatitis by directing skin homing of neutrophils and CD8⁺ T cells.
Lv J; Zou L; Zhao L; Yang W; Xiong Y; Li B; He R
Immunology; 2015 Sep; 146(1):50-8. PubMed ID: 25959240
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
